SABS Competitors & Alternatives
Compare SAB Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
SABS
Main Stock$2.84
Tradestie Score
56
Market Cap
$20.61M
Revenue Growth
-0.6%
Analyst Upside
+309.7%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$6.87
|
$307.12M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.03
|
$304.12M | - | 56 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.59
|
$297.23M | - | 45 | Compare |
|
OMER
Omeros Corporation
|
$16.57
|
$281.75M | 13.3 | 66 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.75
|
$275.54M | - | 62 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.26
|
$269.08M | 0.1 | 50 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.02
|
$265.45M | 21.2 | 34 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.67
|
$240.89M | - | 31 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.66
|
$231.77M | - | 49 | Compare |
More SABS Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry